SecBot SecBot
8-K ·Filed Jun 3, 2026

CORT

CORCEPT THERAPEUTICS INC
BULLISH
Impact 6/10
Horizonweeks Processed5mo ago SEC0001193125-26-254622
8-K context-dependent: Items 8.01
Actionable Insight ▲ Bullish

The DOJ's declination to intervene is a significant de-risking event for Corcept, removing the most severe financial threat from this qui tam action. Monitor for any future developments in the relator's amended complaint, but the absence of government backing substantially weakens the plaintiff's case. The stock may re-rate higher as this overhang lifts.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$72.65
T+0 close · Jun 3, 2026 · via day close
Latest settled
+60.95%
T+60 · $116.93
Vs SPY
+58.45%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 3 $72.65entry
  2. T+1 · 6mo ago +3.08%α +2.68% · $74.89
  3. T+5 · 5mo ago +7.53%α +11.35% · $78.12
  4. T+20 · 5mo ago +24.17%α +25.17% · $90.21
  5. T+60 · 3mo ago +60.95%α +58.45% · $116.93
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Corcept disclosed that the DOJ, California Department of Insurance, and named Plaintiff States have all declined to intervene in a qui tam lawsuit filed by a former employee in February 2017 regarding the sale and promotion of Korlym. The relator served an amended complaint on June 2, 2026, and the company intends to vigorously defend. This removes the risk of government-backed prosecution, significantly reducing the potential liability exposure.

Key Facts

  • DOJ, California Department of Insurance, and named Plaintiff States declined to intervene in qui tam action
  • Lawsuit initiated February 2017 by former employee (Relator Stephen Elliott)
  • DOJ had issued a subpoena in November 2021; company responded in full
  • Relator served amended complaint on June 2, 2026
  • Company intends to vigorously defend against all claims

Financial Impact

No specific financial exposure disclosed; DOJ declination removes government-backed treble damages risk, which could have been material relative to $7.6B market cap

legal exposurecontingent liabilities

Risk Factors

  • Relator may still pursue the case independently without government support
  • Amended complaint could introduce new allegations or theories of liability
  • Discovery costs and management distraction from ongoing litigation

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
83% bullish (12 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-254622
Document: 0001193125-26-254622-index-headers.html0001193125-26-254622
Document: 0001193125-26-254622-index.html0001193125-26-254622
Document: 0001193125-26-254622.txt0001193125-26-254622

Track record

36 reports on CORT

Performance horizon

7 of 8 bullish or bearish reports moved the stock their way by T+20. Best: +63.06% at T+60 after the Feb 24, 2026 report. 9 of 10 went positive at some point.

Filters
  1. Nov 13, 20262d ago Insider Cluster Neutral 2/10 Entry $73.87 Now $69.22 −6.29% settles Dec 15
  2. Nov 10, 20265d ago 144 Neutral 2/10 Entry $74.53 Now $69.22 −7.12% settles Dec 10
  3. Nov 4, 202611d ago Insider Cluster Neutral 2/10 Entry $71.63 Now $69.22 −3.36% settles Dec 4
  4. Nov 3, 202613d ago 8-K Bullish 6/10 Entry $79.22 Now $69.22 −12.62% settles Dec 3
  5. Nov 2, 202613d ago Institutional Cluster Bearish 4/10 Entry $81.93 Now $69.22 +15.51% settles Dec 2
  6. Oct 27, 202619d ago SC 13G/A Neutral 3/10 Entry $86.28 Now $69.22 −19.77% settles Nov 25
  7. Oct 5, 20265w ago Insider Cluster Neutral 3/10 Entry $119.57 to $81.93 Now $69.22 −42.11% ▼ −31.48% −28.30% vs SPY
  8. Sep 23, 20267w ago 8-K Neutral 3/10 Entry $112.94 to $116.28 Now $69.22 −38.71% ▲ +2.96% +2.27% vs SPY
  9. Sep 16, 20268w ago Insider Cluster Bearish 4/10 Entry $114.86 to $113.37 Now $69.22 +39.74% ▲ +1.30% +2.50% vs SPY
  10. Sep 16, 20268w ago Insider Cluster Bearish 4/10 Entry $114.86 to $113.37 Now $69.22 +39.74% ▲ +1.30% +2.75% vs SPY
Showing 10 of 36

US Market Status

Market Closed · Opens Tue (17h 7m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 3, 2026